4.2 Review

Natriuretic Peptides in Heart Failure Atrial and B-type Natriuretic Peptides

Journal

HEART FAILURE CLINICS
Volume 14, Issue 1, Pages 13-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.hfc.2017.08.002

Keywords

B-type natriuretic peptide; N-terminal B-type natriuretic peptide; Midregional pro-atrial natriuretic peptide; Heart failure; Diagnosis; Prognosis

Ask authors/readers for more resources

The natriuretic peptides play a vital role in normal physiology and as counterregulatory hormones in heart failure (HF). Clinical assessment of their levels (for B-type natriuretic peptide [BNP], N-terminal proBNP, and the midregion of N-terminal pro-atrial natriuretic peptide) have become valuable tools in diagnosing patients with HF as well as risk stratifying and guiding therapy. Their roles have further expanded beyond HF to other cardiovascular conditions and for risk stratification in asymptomatic individuals. Understanding the clinical use of these hormones is vital to achieving their full potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available